NVNO Stock Analysis: Buy, Sell, or Hold?
NVNO - enVVeno Medical Corporation Common Stock
$11.93
1.92 (19.18%)
▲
WAIT
LOW Confidence
Last Updated: January 30, 2026
Earnings: Feb 26, 2026
25d
Get Alerted When NVNO Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
2 traders called NVNO this week
50% bullish • 1 bearish
50% bullish • 1 bearish
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR BETTER ENTRY: NVNO is 32.0% above fair value ($9.04). While momentum could continue, risk/reward favors waiting for a pullback.
⏸️ WAIT FOR BETTER ENTRY: NVNO is 32.0% above fair value ($9.04). While momentum could continue, risk/reward favors waiting for a pullback.
In-depth Analysis How we analyze
Valuation Analysis: NVNO is currently trading at $11.93, which is considered extended relative to its 30-day fair value range of $-1.04 to $9.04.
Technical Outlook: Technically, NVNO is in a uptrend. Immediate support is located at $0.30, while resistance sits at $12.79. The stock is showing strong short-term momentum, up 19.2% recently.
Market Sentiment: NVNO has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $12.50 (+24.9%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, NVNO is in a uptrend. Immediate support is located at $0.30, while resistance sits at $12.79. The stock is showing strong short-term momentum, up 19.2% recently.
Market Sentiment: NVNO has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $12.50 (+24.9%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Fair Price Range
$-1.04 -
$9.04
Company Quality Score
56/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
57.9%
Protect Your Profits
NVNO is technically overbought (RSI 83). Consider hedging now to protect against a potential pullback while keeping your upside.
View Profit Protection PlanAll Signals
- BEARISH: Price significantly overextended (+32.0% above fair value)
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+19.2%)
- BULLISH: Trading 24.9% below Wall St target ($12.50)
- WARNING: Recommendation downgraded due to 32.0% overvaluation
Fair Price Analysis
30-Day Fair Range
$-1.04 -
$9.04
Current vs Fair Value
EXTENDED
Support & Resistance Levels
Support Level
$0.31
Resistance Level
$12.79
Current Trend
Uptrend
Fundamental Context
Forward P/E (Next Year Est.)
-10.01
Wall Street Target
$12.50
(+24.9%)
Last updated: January 31, 2026 11:22 AM ET
Data refreshes hourly during market hours. Next update: 12:22 PM
Data refreshes hourly during market hours. Next update: 12:22 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is NVNO showing a specific setup today?
Insider Activity (6 Months)
0
Buys
1
Sells
Net
INSIDERS SELLING
Recent Transactions
Francis Duhay
SELL
4900 shares
2025-09-15
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BSX
Boston Scientific Corp |
STRONG BUY
34 analysts |
$124 | 59 HOLD |
|
SYK
Stryker Corporation |
BUY
32 analysts |
$427 | 68 BUY |
|
MDT
Medtronic PLC |
BUY
32 analysts |
$110 | 63 BUY |
|
PODD
Insulet Corporation |
STRONG BUY
23 analysts |
$374 | 54 HOLD |
|
EW
Edwards Lifesciences Corp |
HOLD
32 analysts |
$97 | 59 HOLD |
Advanced NVNO Option Strategies
Professional options setups generated by AI based on today's NVNO price and gamma walls.
